Pharmacological interaction between ZHPV16E61235 and ZHPV16E7384 was determined using Chou-Talalay analysis (Chou, 2010). Briefly, 5 × 103 cells were seeded onto 96-well plates and subsequently incubated for 2 days with the indicated agents at different concentration combinations. Then, a CCK8 assay was used to measure the combined effect of the two therapeutic agents from different groups on TC-1 and CaSki cells. Using Compusyn software2, dose-effect curves for each regimen and for the combination of agents were plotted and an estimate of the combination index (CI) is achieved. A CI of >1, <1, = 1 denotes antagonism, synergy, and additive effects, respectively.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.